141 related articles for article (PubMed ID: 37198417)
1. Virus-like particle-based delivery of Cas9/guide RNA ribonucleoprotein efficiently edits the brachyury gene and inhibits chordoma growth in vivo.
Hu Y; Lu B; Deng Z; Xing F; Hsu W
Discov Oncol; 2023 May; 14(1):70. PubMed ID: 37198417
[TBL] [Abstract][Full Text] [Related]
2. Synthetic gRNA/Cas9 Ribonucleoprotein Inhibits HIV Reactivation and Replication.
Khanal S; Cao D; Zhang J; Zhang Y; Schank M; Dang X; Nguyen LNT; Wu XY; Jiang Y; Ning S; Zhao J; Wang L; Gazzar ME; Moorman JP; Yao ZQ
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146709
[TBL] [Abstract][Full Text] [Related]
3. CRISPR/Cas9 ribonucleoprotein (RNP) complex enables higher viability of transfected cells in genome editing of acute myeloid cells.
Cheng Q; Xia J; Wang K; Zhang Y; Chen Y; Zhong Q; Wang X; Wu Q
Ann Transl Med; 2022 Aug; 10(16):862. PubMed ID: 36111017
[TBL] [Abstract][Full Text] [Related]
4. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species.
Wang P
mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980
[No Abstract] [Full Text] [Related]
5. Lentiviral Capsid-Mediated
Lu Z; Yao X; Lyu P; Yadav M; Yoo K; Atala A; Lu B
CRISPR J; 2021 Dec; 4(6):914-928. PubMed ID: 33733873
[TBL] [Abstract][Full Text] [Related]
6. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
7. Efficient genome editing using CRISPR/Cas9 ribonucleoprotein approach in cultured Medaka fish cells.
Liu Q; Yuan Y; Zhu F; Hong Y; Ge R
Biol Open; 2018 Aug; 7(8):. PubMed ID: 30072445
[TBL] [Abstract][Full Text] [Related]
8. Small-molecule targeting of brachyury transcription factor addiction in chordoma.
Sharifnia T; Wawer MJ; Chen T; Huang QY; Weir BA; Sizemore A; Lawlor MA; Goodale A; Cowley GS; Vazquez F; Ott CJ; Francis JM; Sassi S; Cogswell P; Sheppard HE; Zhang T; Gray NS; Clarke PA; Blagg J; Workman P; Sommer J; Hornicek F; Root DE; Hahn WC; Bradner JE; Wong KK; Clemons PA; Lin CY; Kotz JD; Schreiber SL
Nat Med; 2019 Feb; 25(2):292-300. PubMed ID: 30664779
[TBL] [Abstract][Full Text] [Related]
9. CRISPR based targeted genome editing of Chlamydomonas reinhardtii using programmed Cas9-gRNA ribonucleoprotein.
Dhokane D; Bhadra B; Dasgupta S
Mol Biol Rep; 2020 Nov; 47(11):8747-8755. PubMed ID: 33074412
[TBL] [Abstract][Full Text] [Related]
10. In Vivo Editing of Macrophages through Systemic Delivery of CRISPR-Cas9-Ribonucleoprotein-Nanoparticle Nanoassemblies.
Lee YW; Mout R; Luther DC; Liu Y; Castellanos-García L; Burnside AS; Ray M; Tonga GY; Hardie J; Nagaraj H; Das R; Phillips EL; Tay T; Vachet RW; Rotello VM
Adv Ther (Weinh); 2019 Oct; 2(10):. PubMed ID: 34095457
[TBL] [Abstract][Full Text] [Related]
11. Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient 'hit-and-run' genome editing.
Lyu P; Javidi-Parsijani P; Atala A; Lu B
Nucleic Acids Res; 2019 Sep; 47(17):e99. PubMed ID: 31299082
[TBL] [Abstract][Full Text] [Related]
12. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
[TBL] [Abstract][Full Text] [Related]
13. Optimization of highly efficient exogenous-DNA-free Cas9-ribonucleoprotein mediated gene editing in disease susceptibility loci in wheat (
Poddar S; Tanaka J; Running KLD; Kariyawasam GK; Faris JD; Friesen TL; Cho MJ; Cate JHD; Staskawicz B
Front Plant Sci; 2022; 13():1084700. PubMed ID: 36704157
[TBL] [Abstract][Full Text] [Related]
14. Engineered extracellular vesicles as versatile ribonucleoprotein delivery vehicles for efficient and safe CRISPR genome editing.
Yao X; Lyu P; Yoo K; Yadav MK; Singh R; Atala A; Lu B
J Extracell Vesicles; 2021 Mar; 10(5):e12076. PubMed ID: 33747370
[TBL] [Abstract][Full Text] [Related]
15. Development of a Small Molecule Downmodulator for the Transcription Factor Brachyury.
Chase DH; Bebenek AM; Nie P; Jaime-Figueroa S; Butrin A; Castro DA; Hines J; Linhares BM; Crews CM
Angew Chem Int Ed Engl; 2024 Apr; 63(14):e202316496. PubMed ID: 38348945
[TBL] [Abstract][Full Text] [Related]
16. Rationally designed nanoparticle delivery of Cas9 ribonucleoprotein for effective gene editing.
Chae SY; Jeong E; Kang S; Yim Y; Kim JS; Min DH
J Control Release; 2022 May; 345():108-119. PubMed ID: 35247491
[TBL] [Abstract][Full Text] [Related]
17. Liposome-Protamine-DNA Nanoparticle-Mediated Delivery of Short Hairpin RNA Targeting Brachyury Inhibits Chordoma Cell Growth.
Hu Y; Singh R; Deng Z; Mintz A; Hsu W
J Biomed Nanotechnol; 2016 Oct; 12(10):1952-61. PubMed ID: 29360338
[TBL] [Abstract][Full Text] [Related]
18. miR-219-5p inhibits proliferation and clonogenicity in chordoma cells and is associated with tumor recurrence.
Wei W; Zhang Q; Wang Z; Yan B; Feng Y; Li P
Oncol Lett; 2016 Dec; 12(6):4568-4576. PubMed ID: 28105164
[TBL] [Abstract][Full Text] [Related]
19. Different Methods of Delivering CRISPR/Cas9 Into Cells.
Chandrasekaran AP; Song M; Kim KS; Ramakrishna S
Prog Mol Biol Transl Sci; 2018; 159():157-176. PubMed ID: 30340786
[TBL] [Abstract][Full Text] [Related]
20. Genome editing of mutant KRAS through supramolecular polymer-mediated delivery of Cas9 ribonucleoprotein for colorectal cancer therapy.
Wan T; Chen Y; Pan Q; Xu X; Kang Y; Gao X; Huang F; Wu C; Ping Y
J Control Release; 2020 Jun; 322():236-247. PubMed ID: 32169537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
